FDA issues guidance on conducting remote interactive evaluations
New guidance provides clarity for regulated drug facilities during COVID-19 pandemic
New guidance provides clarity for regulated drug facilities during COVID-19 pandemic
The FDA is issuing the guidance to describe how it will request and conduct evaluations
The FDA approved one drug and many more are being tested in clinical trials
May 14 - To treat patients with paroxysmal nocturnal hemoglobinuria
May 7 - Can help predict drug uptake and lead to more generic nasal drug products
May 4 - Will discuss effective date, warning metrics, resources and FAQs
Learn how the FDA and its partners are addressing the COVID-19 outbreak
It can lead to many serious problems that’s why it’s important to know your risk factors
Explore resources and tools so you can safely buy prescription medicines online
Your source for the latest drug information.
Know the moment it happens.